STOCK TITAN

PDS Biotechnology Corporation (PDSB) Free Cash Flow by Year

PDSB

PDS Biotechnology Corporation recorded an outflow of $27.8M in free cash flow in fiscal year 2025. This represents an increase of 20.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters PDS Biotechnology Corporation has filed alongside them.

FY2025 annual
Free Cash Flow -$27.8M
YoY +20.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PDSB Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Free Cash Flow-$27.8M+20.8%-$35.1M-4.2%-$33.6MN/AN/AN/AN/AN/A-$40.9M-24.4%-$32.9M-42.6%-$23.1M-117.5%-$10.6M-29.6%-$8.2M

PDSB Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-KQ1'2410-KQ4'2310-QQ3'2310-Q
Free Cash FlowN/AN/A-$3.7M+55.0%-$5.9M+26.0%N/AN/A-$8.2M+2.6%-$8.0M-11.5%N/AN/A-$8.5M-$7.2M

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More PDS Biotechnology Corporation financials

Frequently Asked Questions

What was PDS Biotechnology Corporation's free cash flow in fiscal year 2025?

PDS Biotechnology Corporation recorded an outflow of $27.8M in free cash flow in fiscal year 2025.

How fast is PDS Biotechnology Corporation's free cash flow growing?

PDS Biotechnology Corporation (PDSB) free cash flow rose by 20.8% year over year, from -$35.1M to -$27.8M in fiscal year 2025.

How has PDS Biotechnology Corporation's free cash flow changed over the years?

Across the 13 fiscal years this page covers, PDS Biotechnology Corporation (PDSB) free cash flow went from -$8.2M in fiscal year 2013 to -$27.8M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what PDS Biotechnology Corporation (PDSB) reported on that line in every period on record.